Keros Therapeutics, Inc. (KROS): Weighted Average Diluted Shares
37.86M
Year ended 2025-12-31
+14.5%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 37.86M | +1.1% | 2026-03-04, From 2025-01-01 |
| 2024-12-31 | 37.44M | +27.1% | 2026-03-04, From 2024-01-01 |
| 2023-12-31 | 29.45M | +16.7% | 2025-02-26, From 2023-01-01 |
| 2022-12-31 | 25.24M | +8.2% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | 23.33M | n/c | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | 15.51M | n/a | 2022-03-09, From 2020-01-01 |